The recent recall of Digitek (digoxin) due to twice the appropriate dosage goes back to March 2006. The FDA issued a recall notice at the beginning of May and stated that the distributer, Mylan Pharmaceuticals, and its manufacturer, Actavis Totowa, were voluntarily complying. The drug was distributed under the “Bertek” label. The drug was also marketed under a “UDL” label and distributed by UDL Laboratories, Inc., but no mention of this label is part of the recall.
However, the tablets have been distributed since 2006, more than two years before the recall was announced by the FDA. In class-action lawsuits that have been filed against Actavis, it is alleged that the FDA found problems with Digitek in 2006 at the manufacturing plant in Little Falls, NJ. There is also some concern that there were “unexpected adverse drug events” that go back to 1999.
Since the news of the Digitek recall, users who have been injured have come forward to complain about many of the symptoms of digitalis toxicity, including dizziness, nausea, and kidney damage. If you feel you have suffered “unexpected problems” due to taking Digitek, please contact an experienced injury lawyer in your area.
